Peer Review History
| Original SubmissionApril 22, 2024 |
|---|
|
PONE-D-24-11256Assessing the impact of structural modifications in the construction of surveillance network for transboundary animal diseases: the role of backbone and sentinel nodesPLOS ONE Dear Dr. MESDOUR, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The reviewers recommend that you make improvements to the manuscript. Please attend to all the comments and return the improved manuscript as advised in this letter. Please submit your revised manuscript by Jul 26 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Martin Chtolongo Simuunza, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please update your submission to use the PLOS LaTeX template. The template and more information on our requirements for LaTeX submissions can be found at http://journals.plos.org/plosone/s/latex. 3. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, all author-generated code must be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 4. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 5. Thank you for stating the following financial disclosure: "European Union for the project “EU support to Livestock Disease Surveillance Knowledge Integration” (LIDISKI)" Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 6. Thank you for stating the following in the Acknowledgments Section of your manuscript: "The research was supported by a grant (FOOD/2019/410-957) from the European Union for the project “EU support to Livestock Disease Surveillance Knowledge Integration” (LIDISKI)." We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "European Union for the project “EU support to Livestock Disease Surveillance Knowledge Integration” (LIDISKI)" Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 7. We noted in your submission details that a portion of your manuscript may have been presented or published elsewhere. "This publication is an extended version of a conference proceedings "Complex network & their application 2023", published in the procedeeing, which invited us to submit an extended version of the same article on Plos One." Please clarify whether this [conference proceeding or publication] was peer-reviewed and formally published. If this work was previously peer-reviewed and published, in the cover letter please provide the reason that this work does not constitute dual publication and should be included in the current manuscript. 8. In the online submission form, you indicated that "access to data on request to Sandra Ijoma and Andrea Apolloni, article co-author" All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval. 9. Please amend the manuscript submission data (via Edit Submission) to include author Sandra Ijoma, Muhammad-Bashir Bolajoko, Elena ArsevskaMamadou Ciss, Eric Cardinale, Mathieu Andraud. 10. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The study “Assessing the impact of structural modifications in the construction of surveillance network for transboundary animal diseases: the role of backbone and sentinel nodes” set out to identify critical districts in which to institute surveillance activities among other control activities of TADs with a special focus on Peste des petits ruminants (PPR). The study used data from 10 market surveys in 3 states and employed a mix of standard social network analysis and mathematical modelling approaches to identify the most probable “sentinel districts” in Nigeria. The authors present a strong case in regard to the urgent need to effectively control PPR and eventually eradicated through activities such as building strong and efficient surveillance systems, a key contribution to the global efforts to eradicate PPR. However, the manuscript in current state suffers a few serious methodological and minor scholarly considerations that the authors should consider attending to so as to achieve their set objective (s). General comments The authors conveniently define ‘sentinel nodes’ as those areas that are rapidly infected first in case of disease introduction, a definition that leans more to anatomy (cancer research). I would have thought that since the focus is control of TADs, a definition that is borrowed from epidemiology is more appropriate - sentinel nodes as to mimic sentinel monitoring or surveillance. These would be those districts intentionally identified to enable quick disease detection and patterns that guide more conclusive epidemiological investigations to determine spread mechanisms. For example districts that have a very high in-degree or high betweenness would be very good sentinels for disease surveillance because they simply receive animals from various origins that could potentially introduce disease. Much as the authors apply robust techniques to identify the network backbone that has high potential for surveillance activities a much clearer approach for identifying sentinels for surveillance should have considered. For example, build the network and identify communities (if they exist) and each community selected districts with the highest selected centrality measure (s) – influential nodes and then those become sentinel nodes. Sentinel nodes would make much more sense if the authors then explored them over time (longitudinally) as cross-sectional view of the sentinels doesn’t tell a full picture. The authors need to explain more about their choice of approach to deal with missing/unreliable survey data especially inline with naural network structure of livestock mobility in Nigeria In the epidemic simulation, the authors chose a “district” as the unit to be susceptible or “infected” and simulated the speed and breadth of PPR penetration across the different nodes. The authors need to elaborate more why they ignored other important epidemiological parameters that affect PPR transmission such as the small ruminant population density in each district, vaccination coverage, PPRV “spreadablity” (R0), animals that recover may not be “infectious” in the next cycle of infection etc. A suitable explanation needs to be included such that this study is more reliable. Specific comments The title needs to be revised to include PPR or Nigeria (or both). Or if the title will remain as is, the introduction section of the abstract needs to start off with more general literature about livestock mobility, sentinel nodes etc as PPR seems sneaked in the introductory paragraph of the abstract (given that it is not anywhere in the title). Lines 6—10: Please crosscheck with the journal guidelines on author affiliation addresses otherwise in their current form they are abbreviated to the extent that one can hardly figure them out Line 15: please rectify this ‘sweeping’ statement “....and is transmitted through livestock movements” because it not entirely true Line 20: rework that sentence as it is difficult to comprehend Line 42: a lot of general information is included here without supporting reference. For example, lack of storage facilities – the authors need to state what that means in an ambiguous manner, do you mean fridges/freezers, warehouses? Line 47: please consider introducing the abbreviations in full and then only use them on subsequent mentions. For example, what does “WHOA” stand for? Additionally, thrught the entire manuscript, please write Peste des Petits Ruminants as sentence case (only capitalise the first letter), as it is just a name (noun) of a disease, so only the first letter should be capitalised Line 49: high morbidity and mortality rates: mention some figures and give credit to the sources (as “high rates” does not communicate much) Line 50: The PPR eradication strategy actually stresses vaccination as the main-stay control intervention. Consider adding a sentence to this paragraph to give non specialist readers more context about the eradication plan Line 109: This is the first figure, but it labelled figure 8. The figure numbers need to be harmonised throughout the write up. And what state is represented by color grey? Please rework the figure legend Line 111: please state clearly how many farmers exactly were interviewed per market and was this survey conducted in the same month, repeated observations or just one-off etc? Also consider replaced “were questioned” with “interviewed” Line 114: “and to avoid problems related to the misspelling of village names” , the authors need to explain why they were unable to recruit local enumerators who could correctly spell the names of villages. Otherwise, this sounds like no one can correctly spell names of villages in Nigeria Line 119: the authors need to include an explanation for their assumption of district susceptibility without considering vaccination coverage, animal population density, recovery from PPR confers protection (and animals may or may not be infectious to others etc). Why these assumptions were not included in the model needs to be explained Line 141: more elaboration is needed on “non-observed links”, what are they and how can they be identified without necessarily observing them Line 147: the sentence is vague. Consider re-writing it in a more concise manner Line 151: how was ‘misinformation’ judged? What gold standard did the author use to determine that the responses from the survey contained “inaccurate information”. This needs to be made clear in the methodology. Again, state how many farmers (individual or groups of farmers) were interviewed as opposed to stating that “only some of the farmers” were interviewed Random permutations do not seem to mimic natural small ruminant movement network structures. For example randomly re-ordering links may not necessarily mimic how naturally the “sources of animals eg rural areas” to “urban destination because that is where demand for livestock and their product is” – may not be a scenario one can just assume that the direction of flow can randomly be reversed. In my opinion, in addition to all the innovative approaches employed by the authors to correct for missing/misleading information: The authors needed to use their market survey data and triangulate it with local key informants with subject specific knowledge to validate the reposes from the surveys. Additionally, the authors should have explored other mechanisms of data collection such as participatory mapping exercises with key stakeholders to reconstruct reliable and robust movement networks that are closer to the true picture in Nigeria (as has previously done by other researchers eg <https: 10.1038="" doi.org="" s41598-023-35968-x="">, <https: 10.1098="" doi.org="" rstb.2018.0264=""> ). Otherwise, the authors need to clearly state the epidemiological assumptions behind their choice of correction of missing data Line 177: Once again it should be stated whether ‘frequency of infection’ takes care of the fact that infected animals in one epidemic may not be “infected again” as those animals will no longer be susceptible and thus move into the next class of “recovered”. It is not clear if such assumptions were considered in the simulation exercises. Additionally, for districts with not-large-enough populations of small ruminants, the epidemic will naturally die out once susceptible individuals are exhausted, and therefore I would expect some consideration of small ruminant density as a parameter. The authors need to provide an explanation or at least acknowledge that they are aware Line 231: why did the authors expect the characteristics of nodes (locations eg districts) to change with increasing probability of infection? And also because some nodes were removed , edges re-wired in the different configurations, some changes were really expected even before the analysis. The question is; how do these configurations mimic the natural network structure of small ruminant movement in Nigeria (both static and dynamic) Line 286: figure legend needs to be rewritten so as to clearly communicate what the fiure represents Lines 354: The manuscript is silent about “Data analysis” section eg how the analyses were done, what software tools etc. In addition to the random forest plots, consider using the effect size and then explore visualizing the plots with interpretation of what metrics has the largest or smallest effect sizes (a suggestion)</https:></https:> Reviewer #2: Excellent piece of research. - well described methods and results. Noting i am not a high level expert in network analysis this was helpful! i would like to see some inclusion of the application in the discussion. Sentinel surveillance is cost-effective and if targeted appropriately contributes very relevant data to overall disease control Could tools be developed to make this sustainable for example? I was not able to access a key reference - no.15 to ensure complementarity rather than duplication/permissible overlap. Some minor suggestions/edits: L31 45% 'of the' sentinel L40 "pillar" .. Better 'essential' or similar wording L45 "unify a region" unclear - L37 WHOA --- WOAH L51 "massively" - suggest 'extensively' L60 data's to data L68 "and circulating" not needed L73 "of PPR" … `PPR virus' L74 "line" to 'lineage L77 'ad hoc' (italics) L88 "and if so" - doesnt read well - delete or reformat sentence L147 "tantamount" - paramount / supreme / substantial L286 Fig 2 caption on different page to figure L295 Fig 3 caption on different page to figure L355 Gini References Ref 2 "bavf"? Duplicate refs 30/31 Replace in english for "disponible sur.." and names of months ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Joseph Nkamwesiga Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Assessing the impact of structural modifications in the construction of surveillance network for Peste des petits ruminants disease in Nigeria: the role of backbone and sentinel nodes PONE-D-24-11256R1 Dear Dr. MESDOUR, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Martin Chtolongo Simuunza, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I am generally satisfied with the responses to the queries I raised. However, I believe that this manuscript would benefit from a dedicated "Conclusion" section summarising the takehome mesaage. The manuscript should still be revisited by the authors to rid it of some minor typographical errors that still exist in different sections. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Joseph Nkamwesiga ********** |
| Formally Accepted |
|
PONE-D-24-11256R1 PLOS ONE Dear Dr. MESDOUR, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Martin Chtolongo Simuunza Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .